|
Predominant and concomitant symptoms on admission to PCU Havelhoehe. |
|||||||
| Symptom |
All admissions (A) |
Subgroup (B) |
Subgroup (C) |
Significance |
|||
| All (n = 1467) |
† without sed.(n = 468) |
† with sed. (n = 80) |
p-Values |
||||
|
|
|||||||
| Predominant |
Concomitant |
Predominant |
Concomitant |
Predominant |
Concomitant |
||
| Pain |
29,1% |
56,3% |
27,1% |
54,0% |
37,5% |
70,0% |
n.s. |
| Gastrointestinal (nausea, vomiting, constipation & bowel obstruction) |
17,4% |
71,3% |
11,7%* |
55,9% |
8,8%* |
67,5% |
*p = 0.014 |
| Dyspnoea |
14,6% |
31,2% |
15,5% |
33,1% |
22,5% |
46,3% |
n.s. |
| Psychological distress (anxiety/depression) |
2,4% |
34,0% |
1,7% |
20,9% |
5,0% |
37,5% |
n.s. |
| Cachexia/fatigue |
9,3% |
56,3% |
17,4%** |
65,9% |
12,5% |
66,3% |
**p < 0.001 |
| Cognitive disorder/delirium (drowsiness/agitation) |
8,5% |
29,1% |
11,2% |
29,1% |
3,8% |
13,7% |
n.s. |
| Bleeding |
2,4% |
3,2% |
1,3% |
3,8% |
0,0% |
1,3% |
n.s. |
| Skin (ulceration, oedema) |
5,3% |
42,5% |
3,2% |
31,4% |
2,5% |
35,0% |
n.s. |
| Neurological |
8,9% |
33,6% |
8,7% |
27,1% |
6,3% |
26,3% |
n.s. |
| Others |
2,1% |
34,2% |
2,2% |
22,0% |
1,1% |
14,5% |
n.s. |
Muller-Busch et al. BMC Palliative Care 2003 2:2 doi:10.1186/1472-684X-2-2 |
|||||||